Company Filing History:
1 out of 832,718 Years Active: 2020
Title: Cristina Iancu: Innovator in GLUT5 Inhibition
Introduction
Cristina Iancu is a prominent inventor based in Libertyville, IL (US). She has made significant contributions to the field of medical science, particularly in the development of compounds that target human GLUT5, a glucose transporter. Her work has the potential to impact various disease states and conditions.
Latest Patents
Cristina Iancu holds 1 patent for her invention titled "Human GLUT5 specific inhibitors and methods of treatment." This invention relates to compounds that act as potent ligands (inhibitors) of human GLUT5, which is crucial for transporting fructose. The patent outlines the use of these compounds in ligand assays to discover additional GLUT5 ligands, which may serve as potential drugs. Furthermore, the invention addresses methods for treating conditions mediated through GLUT5, including GLUT5 deficiency syndrome, diabetes (type I and II), cancer, and metabolic diseases such as metabolic syndrome and fatty liver disease.
Career Highlights
Cristina's career is marked by her innovative research and dedication to improving health outcomes through her inventions. Her work has garnered attention in the scientific community, showcasing her expertise in the field of glucose transport and its implications for various diseases.
Collaborations
Cristina has collaborated with notable colleagues, including Tudor Oprea and Cristian George Bologa. These partnerships have contributed to her research and the advancement of her inventions.
Conclusion
Cristina Iancu is a trailblazer in the field of GLUT5 inhibition, with her patent holding promise for treating significant health conditions. Her contributions to medical science reflect her commitment to innovation and improving patient care.